Medical Properties Trust, Inc. Completes 2019 With Record $4.5 Billion in Acquisitions for 64% Growth Rate and Delivers Market-Leading Shareholder Returns
Completes
Fourth Quarter Per Share Net Income of
“2019 was a year of incomparable growth and achievement for MPT,” said
In the fourth quarter alone, continuing the performance of the first nine months of 2019, MPT completed approximately
Aldag added, “While we are not prepared to predict 64% growth again, MPT has already started 2020 with completed acquisitions exceeding
FOURTH QUARTER AND RECENT HIGHLIGHTS
-
Per share net income of
$0.26 and Normalized Funds from Operations (“NFFO”) of$0.35 in the fourth quarter, both on a per diluted share basis; -
Completed the acquisition of 10 acute care hospitals operated by
LifePoint Health, Inc. in six U.S. states for an aggregate purchase price of approximately$700 million ; a$31.0 million (€28.2 million) majority real estate interest in a hospital in Viseu,Portugal ; substantial interest in joint ventures that own two premierMadrid hospitals for an aggregate investment of$130.0 million (€117.3 million); and commenced development of a$27.5 million unique behavioral hospital in theHouston, Texas area; - Completed the highly profitable sale of two acute care hospitals, exiting a market and tenant relationship;
- Completed an inaugural Sterling bond issue with staggered maturities in December, raising £1.0 billion to provide financing for 2019 UK acquisitions and to pre-fund the January acquisition of 30 British hospitals; completed remaining purchase price funding in January with a £700 million unsecured term loan for a blended financing cost of less than 3.0%;
-
Filed a
$1.0 billion at-the-market equity program; and -
Issued 57.5 million shares of common stock for net proceeds of approximately
$1.0 billion .
Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, net income and reconciliations of net income to NFFO, all on a basis comparable to 2018 results, and a reconciliation of pro forma total gross assets to total assets.
PORTFOLIO UPDATE
After completion of the most recent investments,
In December, MPT made a 45% equity investment of approximately
In November, MPT acquired a newly-constructed 37-bed acute care hospital operated by Grupo José de Mello (“JDM”) in Viseu,
In October, MPT agreed to provide a funding commitment of
OPERATING RESULTS AND OUTLOOK
Net income for the fourth quarter and year ended
NFFO for the fourth quarter and year ended
The Company reaffirms an annual run rate of
These estimates do not include the effects, if any, of unexpected real estate operating costs, changes in accounting pronouncements, litigation costs, debt refinancing costs, acquisition costs, currency exchange rate movements, interest rate hedging activities, write-offs of straight-line rent or other non-recurring or unplanned transactions. These estimates may change if the Company acquires or sells assets in amounts that are different from estimates, market interest rates change, debt is refinanced, new shares are issued, additional debt is incurred, other operating expenses vary, income from our equity investments vary from expectations, or existing leases do not perform in accordance with their terms.
Aldag concluded by announcing the promotion of a long-time MPT employee. “I would like to take this opportunity to announce that
CONFERENCE CALL AND WEBCAST
The Company has scheduled a conference call and webcast for
A telephone and webcast replay of the call will be available beginning shortly after the call’s completion through
The Company’s supplemental information package for the current period will also be available on the Company’s website in the Investor Relations section.
About
The statements in this press release that are forward looking are based on current expectations and actual results or future events may differ materially. Words such as "expects," "believes," "anticipates," "intends," "will," "should" and variations of such words and similar expressions are intended to identify such forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results of the Company or future events to differ materially from those expressed in or underlying such forward-looking statements, including without limitation: the satisfaction of all conditions, and the timely closing (if at all) of the transactions described above; annual run-rate net income and NFFO per share; the amount of acquisitions of healthcare real estate, if any; results from potential sales and joint venture arrangements, if any; capital markets conditions; estimated leverage metrics; the repayment of debt arrangements; statements concerning the additional income to the Company as a result of ownership interests in equity investments and the timing of such income; the payment of future dividends, if any; completion of additional debt arrangements, and additional investments; national and international economic, business, real estate and other market conditions; the competitive environment in which the Company operates; the execution of the Company's business plan; financing risks; the Company's ability to maintain its status as a REIT for income tax purposes; acquisition and development risks; potential environmental and other liabilities; and other factors affecting the real estate industry generally or healthcare real estate in particular. For further discussion of the factors that could affect outcomes, please refer to the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | ||||||||||
Consolidated Balance Sheets | ||||||||||
(Amounts in thousands, except for per share data) | December 31, 2019 | December 31, 2018 | ||||||||
Assets | (Unaudited) | (A) | ||||||||
Real estate assets | ||||||||||
Land, buildings and improvements, intangible lease assets, and other |
$ |
8,102,754 |
|
$ |
5,268,459 |
|
||||
Mortgage loans |
|
1,275,022 |
|
|
1,213,322 |
|
||||
Investment in financing leases |
|
2,060,302 |
|
|
684,053 |
|
||||
Gross investment in real estate assets |
|
11,438,078 |
|
|
7,165,834 |
|
||||
Accumulated depreciation and amortization |
|
(570,042 |
) |
|
(464,984 |
) |
||||
Net investment in real estate assets |
|
10,868,036 |
|
|
6,700,850 |
|
||||
Cash and cash equivalents |
|
1,462,286 |
|
|
820,868 |
|
||||
Interest and rent receivables |
|
31,357 |
|
|
25,855 |
|
||||
Straight-line rent receivables |
|
334,231 |
|
|
220,848 |
|
||||
Equity investments |
|
926,990 |
|
|
520,058 |
|
||||
Other loans |
|
544,832 |
|
|
373,198 |
|
||||
Other assets |
|
299,599 |
|
|
181,966 |
|
||||
Total Assets |
$ |
14,467,331 |
|
$ |
8,843,643 |
|
||||
Liabilities and Equity | ||||||||||
Liabilities | ||||||||||
Debt, net |
$ |
7,023,679 |
|
$ |
4,037,389 |
|
||||
Accounts payable and accrued expenses |
|
291,489 |
|
|
204,325 |
|
||||
Deferred revenue |
|
16,098 |
|
|
13,467 |
|
||||
Obligations to tenants and other lease liabilities |
|
107,911 |
|
|
27,524 |
|
||||
Total Liabilities |
|
7,439,177 |
|
|
4,282,705 |
|
||||
Equity | ||||||||||
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding |
|
- |
|
|
- |
|
||||
Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 517,522 shares at December 31, 2019 and 370,637 shares at December 31, 2018 |
|
518 |
|
|
371 |
|
||||
Additional paid-in capital |
|
7,008,199 |
|
|
4,442,948 |
|
||||
Retained earnings |
|
83,012 |
|
|
162,768 |
|
||||
Accumulated other comprehensive loss |
|
(62,905 |
) |
|
(58,202 |
) |
||||
Treasury shares, at cost |
|
(777 |
) |
|
(777 |
) |
||||
Total Medical Properties Trust, Inc. Stockholders' Equity |
|
7,028,047 |
|
|
4,547,108 |
|
||||
Non-controlling interests |
|
107 |
|
|
13,830 |
|
||||
Total Equity |
|
7,028,154 |
|
|
4,560,938 |
|
||||
Total Liabilities and Equity |
$ |
14,467,331 |
|
$ |
8,843,643 |
|
||||
(A) Financials have been derived from the prior year audited financial statements. | ||||||||||
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | ||||||||||||||||||
Consolidated Statements of Income | ||||||||||||||||||
(Unaudited) | ||||||||||||||||||
(Amounts in thousands, except for per share data) | For the Three Months Ended | For the Twelve Months Ended | ||||||||||||||||
December 31, 2019 | December 31, 2018 | December 31, 2019 | December 31, 2018 | |||||||||||||||
Revenues | ||||||||||||||||||
Rent billed |
$ |
130,310 |
|
$ |
104,267 |
|
$ |
474,151 |
|
$ |
473,343 |
|
||||||
Straight-line rent |
|
33,643 |
|
|
25,584 |
|
|
110,456 |
|
|
74,741 |
|
||||||
Income from financing leases |
|
52,364 |
|
|
18,370 |
|
|
119,617 |
|
|
73,983 |
|
||||||
Interest and other income |
|
40,121 |
|
|
32,357 |
|
|
149,973 |
|
|
162,455 |
|
||||||
Total revenues |
|
256,438 |
|
|
180,578 |
|
|
854,197 |
|
|
784,522 |
|
||||||
Expenses | ||||||||||||||||||
Interest |
|
70,434 |
|
|
50,910 |
|
|
237,830 |
|
|
223,274 |
|
||||||
Real estate depreciation and amortization |
|
44,152 |
|
|
32,866 |
|
|
152,313 |
|
|
133,083 |
|
||||||
Property-related (A) |
|
8,598 |
|
|
2,414 |
|
|
23,992 |
|
|
9,237 |
|
||||||
General and administrative |
|
27,402 |
|
|
21,734 |
|
|
96,411 |
|
|
81,003 |
|
||||||
Total expenses |
|
150,586 |
|
|
107,924 |
|
|
510,546 |
|
|
446,597 |
|
||||||
Other income (expense) | ||||||||||||||||||
Gain (loss) on sale of real estate and other, net |
|
20,467 |
|
|
(1,437 |
) |
|
20,529 |
|
|
671,385 |
|
||||||
Earnings from equity interests |
|
4,416 |
|
3,623 |
|
|
16,051 |
|
|
14,165 |
|
|||||||
Unutilized financing fees |
|
(1,233 |
) |
|
- |
|
|
(6,106 |
) |
|
- |
|
||||||
Other |
|
1,152 |
|
|
226 |
|
|
(345 |
) |
|
(4,071 |
) |
||||||
Total other income |
|
24,802 |
|
|
2,412 |
|
|
30,129 |
|
|
681,479 |
|
||||||
Income before income tax |
|
130,654 |
|
|
75,066 |
|
|
373,780 |
|
|
1,019,404 |
|
||||||
Income tax (expense) benefit |
|
(731 |
) |
|
3,875 |
|
|
2,621 |
|
|
(927 |
) |
||||||
Net income |
|
129,923 |
|
|
78,941 |
|
|
376,401 |
|
|
1,018,477 |
|
||||||
Net income attributable to non-controlling interests |
|
(285 |
) |
|
(458 |
) |
|
(1,717 |
) |
|
(1,792 |
) |
||||||
Net income attributable to MPT common stockholders |
$ |
129,638 |
|
$ |
78,483 |
|
$ |
374,684 |
|
$ |
1,016,685 |
|
||||||
Earnings per common share - basic: | ||||||||||||||||||
Net income attributable to MPT common stockholders |
$ |
0.26 |
|
$ |
0.21 |
|
$ |
0.87 |
|
$ |
2.77 |
|
||||||
Earnings per common share - diluted: | ||||||||||||||||||
Net income attributable to MPT common stockholders |
$ |
0.26 |
|
$ |
0.21 |
|
$ |
0.87 |
|
$ |
2.76 |
|
||||||
Weighted average shares outstanding - basic |
|
493,593 |
|
|
366,655 |
|
|
427,075 |
|
|
365,364 |
|
||||||
Weighted average shares outstanding - diluted |
|
494,893 |
|
|
367,732 |
|
|
428,299 |
|
|
366,271 |
|
||||||
Dividends declared per common share |
$ |
0.26 |
|
$ |
0.25 |
|
$ |
1.02 |
|
$ |
1.00 |
|
||||||
(A) Includes $3.4 million and $14.8 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three and twelve months ended December 31, 2019, respectively. These costs are required to be presented on a gross basis (with offset included in Interest and other income), following our adoption of the new lease accounting standard on January 1, 2019. We presented similar items in the prior year on a net basis. | ||||||||||||||||||
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | |||||||||||||||||||
Reconciliation of Net Income to Funds From Operations | |||||||||||||||||||
(Unaudited) | |||||||||||||||||||
(Amounts in thousands, except for per share data) | For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||||
December 31, 2019 | December 31, 2018 | December 31, 2019 | December 31, 2018 | ||||||||||||||||
FFO information: | |||||||||||||||||||
Net income attributable to MPT common stockholders |
$ |
129,638 |
|
$ |
78,483 |
|
$ |
374,684 |
|
$ |
1,016,685 |
|
|||||||
Participating securities' share in earnings |
|
(954 |
) |
|
(2,877 |
) |
|
(2,308 |
) |
|
(3,685 |
) |
|||||||
Net income, less participating securities' share in earnings |
$ |
128,684 |
|
$ |
75,606 |
|
$ |
372,376 |
|
$ |
1,013,000 |
|
|||||||
Depreciation and amortization |
|
53,497 |
|
|
39,406 |
|
|
183,921 |
|
|
143,720 |
|
|||||||
(Gain) loss on sale of real estate and other, net |
|
(20,467 |
) |
|
1,437 |
|
|
(20,529 |
) |
|
(671,385 |
) |
|||||||
Funds from operations |
$ |
161,714 |
|
$ |
116,449 |
|
$ |
535,768 |
|
$ |
485,335 |
|
|||||||
Write-off of straight-line rent and other, net of tax benefit |
|
8,307 |
|
|
387 |
|
|
15,539 |
|
|
18,002 |
|
|||||||
Unutilized financing fees |
|
1,233 |
|
|
- |
|
|
6,106 |
|
|
- |
|
|||||||
Release of income tax valuation allowance |
|
- |
|
|
(4,405 |
) |
|
- |
|
|
(4,405 |
) |
|||||||
Acquisition costs, net of tax benefit |
|
- |
|
|
- |
|
|
- |
|
|
2,072 |
|
|||||||
Normalized funds from operations |
$ |
171,254 |
|
$ |
112,431 |
|
$ |
557,413 |
|
$ |
501,004 |
|
|||||||
Share-based compensation |
|
10,069 |
|
|
4,810 |
|
|
32,188 |
|
|
16,505 |
|
|||||||
Debt costs amortization |
|
2,761 |
|
|
1,991 |
|
|
9,675 |
|
|
7,534 |
|
|||||||
Straight-line rent revenue and other |
|
(48,836 |
) |
|
(30,528 |
) |
|
(145,598 |
) |
|
(105,072 |
) |
|||||||
Adjusted funds from operations |
$ |
135,248 |
|
$ |
88,704 |
|
$ |
453,678 |
|
$ |
419,971 |
|
|||||||
Per diluted share data: | |||||||||||||||||||
Net income, less participating securities' share in earnings |
$ |
0.26 |
|
$ |
0.21 |
|
$ |
0.87 |
|
$ |
2.76 |
|
|||||||
Depreciation and amortization |
|
0.11 |
|
|
0.11 |
|
|
0.43 |
|
|
0.39 |
|
|||||||
(Gain) loss on sale of real estate and other, net |
|
(0.04 |
) |
|
- |
|
|
(0.05 |
) |
|
(1.83 |
) |
|||||||
Funds from operations |
$ |
0.33 |
|
$ |
0.32 |
|
$ |
1.25 |
|
$ |
1.32 |
|
|||||||
Write-off of straight-line rent and other, net of tax benefit |
|
0.02 |
|
|
- |
|
|
0.04 |
|
|
0.05 |
|
|||||||
Unutilized financing fees |
|
- |
|
|
- |
|
|
0.01 |
|
|
- |
|
|||||||
Release of income tax valuation allowance |
|
- |
|
|
(0.01 |
) |
|
- |
|
|
(0.01 |
) |
|||||||
Acquisition costs, net of tax benefit |
|
- |
|
|
- |
|
|
- |
|
|
0.01 |
|
|||||||
Normalized funds from operations |
$ |
0.35 |
|
$ |
0.31 |
|
$ |
1.30 |
|
$ |
1.37 |
|
|||||||
Share-based compensation |
|
0.02 |
|
|
0.01 |
|
|
0.08 |
|
|
0.05 |
|
|||||||
Debt costs amortization |
|
0.01 |
|
|
0.01 |
|
|
0.02 |
|
|
0.02 |
|
|||||||
Straight-line rent revenue and other |
|
(0.11 |
) |
|
(0.09 |
) |
|
(0.34 |
) |
|
(0.29 |
) |
|||||||
Adjusted funds from operations |
$ |
0.27 |
|
$ |
0.24 |
|
$ |
1.06 |
|
$ |
1.15 |
|
|||||||
Notes: |
(A) Certain line items above (such as real estate depreciation) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with the activity of all of our equity interests in the "Earnings from equity interests" line on the consolidated statements of income. |
(B) Investors and analysts following the real estate industry utilize funds from operations, or FFO, as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or NAREIT, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures. |
In addition to presenting FFO in accordance with the NAREIT definition, we also disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs necessary to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our financial performance or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity. |
We calculate adjusted funds from operations, or AFFO, by subtracting from or adding to normalized FFO (i) non-cash revenue, (ii) non-cash share-based compensation expense, and (iii) amortization of deferred financing costs. AFFO is an operating measurement that we use to analyze our results of operations based on the receipt, rather than the accrual, of our rental revenue and on certain other adjustments. We believe that this is an important measurement because our leases generally have significant contractual escalations of base rents and therefore result in recognition of rental income that is not collected until future periods, and costs that are deferred or are non-cash charges. Our calculation of AFFO may not be comparable to AFFO or similarly titled measures reported by other REITs. AFFO should not be considered as an alternative to net income (calculated pursuant to GAAP) as an indicator of our results of operations or to cash flow from operating activities (calculated pursuant to GAAP) as an indicator of our liquidity. |
MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES | ||||||||
Annual Run-Rate Guidance Reconciliation | ||||||||
(Unaudited) | ||||||||
Annual Run-Rate Guidance - Per Share(1) | ||||||||
Low | High | |||||||
Net income attributable to MPT common stockholders |
$ |
1.24 |
$ |
1.27 |
||||
Participating securities' share in earnings |
|
- |
|
- |
||||
Net income, less participating securities' share in earnings |
$ |
1.24 |
$ |
1.27 |
||||
Depreciation and amortization |
|
0.41 |
|
0.41 |
||||
Funds from operations |
$ |
1.65 |
$ |
1.68 |
||||
Other adjustments |
|
- |
|
- |
||||
Normalized funds from operations |
$ |
1.65 |
$ |
1.68 |
||||
(1) The guidance is based on current expectations and actual results or future events may differ materially from those expressed in this table, which is a forward-looking statement within the meaning of the federal securities laws. Please refer to the forward-looking statement included in this press release and our filings with the Securities and Exchange Commission for a discussion of risk factors that affect our performance. |
||||||||
Pro Forma Total Gross Assets | |||
(Unaudited) | |||
(Amounts in thousands) | December 31, 2019 | ||
Total Assets |
$ |
14,467,331 |
|
Add: | |||
Binding real estate commitments on new investments(2) |
|
1,988,550 |
|
Unfunded amounts on development deals and commenced capital improvement projects(3) |
|
163,370 |
|
Accumulated depreciation and amortization |
|
570,042 |
|
Incremental gross assets of our joint ventures(4) |
|
563,911 |
|
Proceeds from new £700 million 5-year term loan effective January 6, 2020 |
|
927,990 |
|
Less: | |||
Cash used for funding the transactions above (including proceeds from the £700 million term loan) |
|
(2,151,920 |
) |
Pro Forma Total Gross Assets(5) |
$ |
16,529,274 |
|
(2) Reflects the acquisition of 30 facilities in the United Kingdom on January 8, 2020. |
|||
(3) Includes $41.7 million unfunded amounts on ongoing development projects and $121.7 million unfunded amounts on capital improvement projects and development projects that have commenced rent. |
|||
(4) Adjustment to reflect our share of our joint ventures' gross assets. |
|||
(5) Pro forma total gross assets is total assets before accumulated depreciation/amortization and assumes all real estate binding commitments on new investments and unfunded amounts on development deals and commenced capital improvement projects are fully funded using cash on hand. We believe pro forma total gross assets is useful to investors as it provides a more current view of our portfolio and allows for a better understanding of our concentration levels as our binding commitments close and our other commitments are fully funded. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200206005527/en/
Source:
Tim Berryman
Director – Investor Relations
Medical Properties Trust, Inc.
(205) 969-3755
tberryman@medicalpropertiestrust.com